Shareholdings
| Concept |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2022-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholdings | ||||||||||||||||||||
| Reporting company | ||||||||||||||||||||
| Details of specified investment shares held for purposes other than pure investment | ||||||||||||||||||||
| Issue |
㈱ほくやく・竹山ホールディングス
|
アルフレッサ
ホールディングス㈱
|
アステナホールディングス㈱
|
キッセイ薬品工業㈱
|
Roivant Sciences Ltd.
|
㈱バイタルケーエスケー・ホールディングス
|
㈱マツキヨココカラ＆カンパニー
|
㈱メディパルホールディングス
|
㈱スズケン
|
Cogstate Ltd.
|
— | — | — | — | — | — | — | — | — | — |
| Number of shares |
546,005
xbrli:shares
|
2,302,724
xbrli:shares
|
56,608
xbrli:shares
|
474,000
xbrli:shares
|
874,957
xbrli:shares
|
642,154
xbrli:shares
|
2,815,000
xbrli:shares
|
129,395
xbrli:shares
|
1,040,945
xbrli:shares
|
11,738,243
xbrli:shares
|
2,815,000
xbrli:shares
|
125,100
xbrli:shares
|
1,040,945
xbrli:shares
|
11,738,243
xbrli:shares
|
546,005
xbrli:shares
|
3,452,724
xbrli:shares
|
56,608
xbrli:shares
|
474,000
xbrli:shares
|
xbrli:shares
|
642,154
xbrli:shares
|
| Carrying amount |
360,000,000
JPY
|
3,912,000,000
JPY
|
25,000,000
JPY
|
1,211,000,000
JPY
|
529,000,000
JPY
|
472,000,000
JPY
|
12,203,000,000
JPY
|
261,000,000
JPY
|
3,779,000,000
JPY
|
2,484,000,000
JPY
|
13,878,000,000
JPY
|
266,000,000
JPY
|
4,502,000,000
JPY
|
916,000,000
JPY
|
412,000,000
JPY
|
7,365,000,000
JPY
|
37,000,000
JPY
|
1,161,000,000
JPY
|
JPY
|
507,000,000
JPY
|
| Whether issuer of aforementioned shares holds reporting company's shares |
有
|
有
|
有
|
有
|
無
|
有
|
有
|
有
|
有
|
無
|
— | — | — | — | — | — | — | — | — | — |